Literature DB >> 191682

Hyperparathyoidism: influence of glomerular filtration rate on urinary excretion of cyclic AMP.

H Schmidt-Gayk, R Stengel, H Haueisen, M Hüfner, E Ritz, K H Jakobs.   

Abstract

Urinary cyclic AMP excretion per 24 h or per g creatinine in primary hyperparathyroidism (1 degrees HPT) has been evaluated by several authors with conflicting results. In 50 patients with 1 degrees HPT, 25 patients with secondary (2 degrees) HPT and 35 healthy control persons we determined urinary cyclic AMP per 24 h or per g creatinine. These parameters did not satisfactorily discriminate patients from controls, especially when glomerular filtration rate (GFR) as determined by creatinine clearance was reduced. Since urinary cyclic AMP is derived from plasma by glomerular filtration and from kidney by tubular production-the amount of tubules is reflected by GFR-the cyclic nucleotide was related to GFR. In controls urinary cyclic AMP correlated better with GFR than with creatinine excretion. Additionally, in 45 of 50 patients with 1 degrees HPT and in all with 2 degrees HPT, urinary cyclic AMP/GFR was raised. In 1 degrees HPT serum levels of parathyroid hormone correlated closer with urinary cyclic AMP/GFR than with urinary cyclic AMP/g creatinine. The ratio cyclic AMP/GFR decreased to normal or subnormal values after removal of adenomatous or hyperplastic glands in 1 degrees HPT and during infusion of calcium in 2 degrees HPT. In 50 patients with renal lithiasis caused by diseases other than 1 degrees HPT (anatomical variations, pyelonephritis, immobilization after tetraplegia) the ratio cyclic AMP/GFR was not raised. Urinary cyclic AMP/GFR, therefore, reflects parathyroid hormone excess more reliably than cyclic AMP/g creatinine.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 191682     DOI: 10.1007/bf01484728

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  14 in total

Review 1.  [Extracellular cyclic nucleotides: occurrence, analysis and diagnostic significance (author's transl)].

Authors:  K D Gerbitz; O H Wieland
Journal:  Z Klin Chem Klin Biochem       Date:  1973-06

2.  Evaluation of urinary cyclic 3'5'-adenosine monophosphate excretion in the differential diagnosis of hypercalcemia.

Authors:  P H Dohan; K Yamashita; P R Larsen; B Davis; L Deftos; J B Field
Journal:  J Clin Endocrinol Metab       Date:  1972-12       Impact factor: 5.958

3.  Renal handling of 3'-5'-cyclic AMP in the rat. The possible role of luminal 3'-5'-cyclic AMP in the tubular reabsorption of phosphate.

Authors:  D Butlen; S Jard
Journal:  Pflugers Arch       Date:  1972       Impact factor: 3.657

4.  Cyclic nucleotide-dependent protein kinases. 8. An assay method for the measurement of adenosine 3',5'-monophosphate in various tissues and a study of agents influencing its level in adipose cells.

Authors:  J F Kuo; P Greengard
Journal:  J Biol Chem       Date:  1970-08-25       Impact factor: 5.157

5.  Factors influencing the urinary excretion of 3',5'-adenosine monophosphate in humans.

Authors:  A L Taylor; B B Davis; L G Pawlson; J B Josimovich; D H Mintz
Journal:  J Clin Endocrinol Metab       Date:  1970-03       Impact factor: 5.958

6.  Letter: Variation of cyclic-A.M.P. excretion with urine volume.

Authors:  P Owen; A C Moffat
Journal:  Lancet       Date:  1973-11-24       Impact factor: 79.321

7.  Radioimmunoassay for human parathyroid hormone.

Authors:  J Woo; F R Singer
Journal:  Clin Chim Acta       Date:  1974-07-31       Impact factor: 3.786

8.  [Determination of cyclic adenosine 3',5'-monophosphate (cAMP) in urine for the diagnosis of primary hyperparathyroidism].

Authors:  H Schmidt-Gayk; H D Röher; H W Seyberth
Journal:  Chirurg       Date:  1973-06       Impact factor: 0.955

9.  Kinetic parameters and renal clearances of plasma adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate in man.

Authors:  A E Broadus; N I Kaminsky; J G Hardman; E W Sutherland; G W Liddle
Journal:  J Clin Invest       Date:  1970-12       Impact factor: 14.808

10.  Effects of parathyroid hormone on plasma and urinary adenosine 3',5'-monophosphate in man.

Authors:  N I Kaminsky; A E Broadus; J G Hardman; D J Jones; J H Ball; E W Sutherland; G W Liddle
Journal:  J Clin Invest       Date:  1970-12       Impact factor: 14.808

View more
  2 in total

1.  Diagnosis and treatment of primary hyperparathyroidism.

Authors:  M A Dambacher; U Binswanger; J A Fischer
Journal:  Urol Res       Date:  1979-09

2.  Urinary cAMP activity in chronic renal failure.

Authors:  M Z Mocan; C Erem; S Ulusoy
Journal:  Int Urol Nephrol       Date:  1998       Impact factor: 2.370

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.